Source link : https://newshealth.biz/health-news/fda-reviewers-flag-inconsistent-data-for-rexulti-in-ptsd/
(MedPage Today) — Whether brexpiprazole (Rexulti) is effective as adjunctive treatment for post-traumatic stress disorder (PTSD) will be debated at an FDA advisory committee meeting on Friday. The atypical antipsychotic is under review as an… Source link : https://www.medpagetoday.com/psychiatry/anxietystress/116564 Author : Publish date : 2025-07-17 21:46:00 Copyright for syndicated content belongs to the linked Source.
The post FDA Reviewers Flag Inconsistent Data for Rexulti in PTSD first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-17 21:46:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8